Shepherd Ventures

Shepherd Ventures was founded in 2001 and is headquartered in San Diego, part of Southern California&s;s Tech Coast, with easy access to

Business Model: B2B

Revenue: $13.5M

Employees: 2-10

Rankings

Detailed Shepherd Ventures Information

Geographic Data

Shepherd Ventures headquarters map

Address: 11696 Sorrento Valley Rd

City: San Diego

State: CA

Zip: 92121

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Shepherd Ventures was founded in 2001 and is headquartered in San Diego, part of Southern California&s;s Tech Coast, with easy access to other technology centers throughout the region. The four original Managing Directors of Shepherd Ventures were George Kenney, Peter Fisher, Tom Siegel and Richard Kuntz. The region has vibrant high technology and life sciences industries, is underserved by the venture capital community, and offers compelling investment opportunities. Shepherd Ventures focus is on information technology and life sciences companies characterized by passionate and experienced management teams, compelling value propositions and extraordinary upside potential. They concentrate on companies located in Southern California and the Southwest, particularly San Diego, where they believe there is a significant shortage of venture capital. Their objective is to generate significant capital appreciation through a balanced portfolio of first and later stage equity investments in carefully selected, wisely shepherded growth companies. First stage companies are those with products that incorporate a disruptive technology, that are (or are about to be) commercially released, and that are capable of creating a valuable new paradigm in their category. In particular, Shepherd Ventures look for companies with completed products, where sales channels have been defined, and when possible, validated by a purchase order or letter of intent from a bona fide customer. Companies should exhibit a sustainable competitive advantage that will drive them to market or sector dominance and a credible path to profitability. Investments in these companies may be part of the first or second round of institutional capital. Seed stage opportunities will generally not be considered. Later stage companies are those that either have received prior rounds of venture capital, or have achieved growth and operational maturity without venture funding. These companies would be established technology companies with existing revenue and proven management teams. They likely will have profitable products, brand identity, market traction, and satisfied customers. The Shepherd Ventures Managing Directors, Venture Partners and Advisors are industry leaders who have extensive experience operating, guiding and investing in first and later stage information technology and life sciences companies. Shepherd Ventures takes pride in its people. They have a dynamic team of experienced professionals who hold diverse, yet extremely relevant backgrounds. The Shepherd team is disciplined, committed, capable, and always eager to assist Shepherd Ventures companies in any area they need to succeed. While Shepherd Ventures structure and lead most of the investments they make, they recognize the value of partnering to help entrepreneurs execute and build world class businesses.

Contact Phone:
+18585094744

Contact Email:

Announced Date Company Transaction Money Raised
2/2007 Quickoffice Series D 7M
2/2008 Digital Orchid Venture Round 245.3k
12/2009 Revance Therapeutics Series D 0
12/2005 Oculir Series A 7.3M
2/2009 Sendio Series B 0
12/2003 Emergent Respiratory Venture Round 5.3M
11/2002 Skylight Healthcare Systems Series B 7.8M
1/2005 CEYX Series A 4.5M
5/2008 Quickoffice Series C 3M
10/2005 NP Photonics Series A 2M
6/2005 SiliconSystems Series B -
6/2006 Specific Media Series A 10M
8/2011 TakeLessons Series A 0
10/2002 Voyager Systems Venture Round 7.5M
2/2007 Andigilog Series B 0
10/2021 Cyabra Series A 0
5/2005 Quickoffice Series C 7M
6/2011 Revance Therapeutics Series D 45M
1/2006 Quickoffice Venture Round 11.5M
2/2006 Digital Orchid Series B 6M
7/2005 NP Photonics Series A 5M
4/2009 WiSpry Series C 0
12/2007 Revance Therapeutics Series C 0
3/2018 Carepoynt Convertible Note -
10/2021 Cyabra Series A 0
3/2018 Carepoynt Convertible Note -
8/2011 TakeLessons Series A 0
6/2011 Revance Therapeutics Series D 0
12/2009 Revance Therapeutics Series D 0
4/2009 WiSpry Series C 0
2/2009 Sendio Series B 0
5/2008 Quickoffice Venture Round 0
2/2008 Digital Orchid Venture Round 0
12/2007 Revance Therapeutics Series C 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research